While other agro companies accuse financial complications, Rizobacter closed a financing agreement for US $20 million and a 5 -year period.
In an extremely complex scenario for companies belonging to agriculture, Rizobacteroperational subsidiary of Bioceres Crops Solutions (Nasdaq: Biox), closed a financing agreement with Rabobank For an amount of US $20 million and a period of 5 years, aimed at strengthening the company’s working capital.
“This agreement is of strategic relevance when it comes to successfully transit volatility periods such as the one shown by the local and global agricultural market,” they said in the company. “Rabobank is the natural partner to strengthen the capital structure that requires the escalation of our existing business through Rizobacter, as well as the opportunities for regional diversification and the synergies of the technology portfolio that brings the combination with profarm,” they said.
Differentiate in a complex scenario
Rizobacter comes Cancellations of maturity of its negotiable obligations (ON) for about US $ 42 million approximately in the last two months. In February, the eighth payment of its series VIII series was made, with a total disbursement of just over US $12 million. Consulted, in the firm they pointed out that, with this movement, it was sought to show its commitment to investors and reinforces its position in the financial market, where in repeated opportunities resorted to financing.
One of the keys to boost this differentiation must be sought in the firm’s Core. The company is dedicated to research, development, production and marketing Microbiological agroinsumumosumosumosumosumosumosumos for crop protection and nutrition, including fertilizers, inoculants and adjuvants. The company has a trajectory of more than 35 years in the Argentine market, a diversified portfolio of products, operations in Argentina, Brazil, Uruguay, Paraguay, Bolivia, the United States, South Africa, Colombia and France, and sales in more than 40 countries .
As explained in the sector, although Rizobacter operates in a context of high competition, the quality and differentiation of its products allows the company to maintain a high market positioning, which derives in the possibility of setting prices above standard products.
The situation of the Grobo and Sancor
However, there are several firms that have been declared in trouble. The situation of the Los Grobo Group, for example, is really critical as evidenced in the results of its last balance, partial, for the six -month period ended in December last year. The Agricultural and Agrofina Grobo, the two main firms of the company who requested the creditors in early February lost more than $ 42,700 million.
As Condo reported, one of the most alarming points is that the Agricultural Grobo has a negative net worth, which places it in the cause of dissolution according to the General Societies Law. The company, of the Group Los Gobo, registered in the last semester of 2024 a turnover of $ 318,653 million, but the combination of high costs, operating expenses and a high financial impact resulted in a net loss of $ 26,565 million, a number that almost quadruples red of the same period of the previous year. This fall further deepened its solvency crisis: its total liability amounts to $ 333,190 million, while its assets total $ 319,972 million, which left it with a negative net worth at $ 13,218 million.
On the other hand, in his search to avoid bankruptcy, Sancor formalized the preventive contest of creditors this week. With a minimum reduced production, hundreds of millionaire layoffs and debts, Sancor initiates a key process to renegotiate with its creditors and guarantee their survival.
Source: Ambito
I am a 24-year-old writer and journalist who has been working in the news industry for the past two years. I write primarily about market news, so if you’re looking for insights into what’s going on in the stock market or economic indicators, you’ve come to the right place. I also dabble in writing articles on lifestyle trends and pop culture news.
